TAK-536TCH
TAK-536TCH/CPH-004
Phase 1 small_molecule completed
Quick answer
TAK-536TCH for Hypertension is a Phase 1 program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hypertension
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed